"The Board is committed to a process that adheres to the highest possible standards, and is fair, transparent, merit-based, and conducted with due diligence and professionalism," Norbert Hauser, the chair of the board, said in a statement released Monday.
The board was unable to choose a new executive director “due to issues encountered in the recruitment process,” according to the statement.
It added: “While expressing its complete support for the work of the Nominations Committee, the Board decided to restart the process.”
The three finalists being considered to lead the Swiss organization — which distributes roughly $4.5 billion each year to country-led programs combatting the three infectious diseases — were Dr. Muhammad Ali Pate, a former health minister of Nigeria; Subhanu Saxena, the former chief executive of Indian pharmaceutical company Cipla; and Helen Clark, administrator of the United Nations Development Programme and former New Zealand prime minister.
As Devex reported last week, a number of global health and development leaders had mixed feelings or were disappointed with the selection process because it had not generated candidates known for visionary global health leadership.
Mark Dybul, the current executive director, will step down after four years on the job when his term ends May 31.
As a Devex Impact associate editor, Adva leads coverage of the intersection of business and international development. From partnerships to trade and social entrepreneurship to impact investing, she enjoys exploring the role the private sector and private capital play in development. Previously, she has worked as a reporter at newspapers in both the U.S. and South Africa. Most recently, she has been ghostwriting a memoir for a former child slave and NGO founder in Ghana.
Subscribe to Devex Newswire
Top international development headlines emailed to you every day